Millennium Management
CDTX

Millennium Management’s Cidara Therapeutics CDTX Stock Holding History

Millennium Management’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-8,750
Closed -$700K – 3813
2018
Q1 		$700K Buy
+8,750
New +$1.2M ﹤0.01% 2872

Millennium Management's CDTX Position: Q1 2026 in Review

Millennium Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 509,647 shares — an estimated $113M sold.

Millennium Management first reported a position in CDTX in Q2 2015 and held it in 30 quarters. The position peaked at $113M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • Millennium Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 509,647 Cidara Therapeutics shares in Q1 2026, an estimated $113M.
  • Millennium Management first reported a position in Cidara Therapeutics in Q2 2015 and held it in 30 quarters.
  • Millennium Management's Cidara Therapeutics position peaked at $113M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.